BPC-157 Dosage Chart 2026 — Research Peptide Reference Guide

Medical Disclaimer

This website is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or stopping any medication or supplement. Dosage information reflects published FDA-approved labeling or publicly available clinical trial data — individual treatment decisions must be made by a licensed physician.

About BPC-157 (Body Protection Compound-157)

BPC-157 is a synthetic peptide derived from a protein found in human gastric juice. It is studied for tissue healing and anti-inflammatory effects. BPC-157 is NOT FDA-approved and is not a GLP-1 drug. It is used strictly in research settings. This page is for informational reference only.

Indication

Research peptide. NOT for human clinical use. FDA has warned against BPC-157 products (August 2023). Consult a physician.

Research / Trial Dosing Reference

Dosing data from published clinical trials. Not an approved prescription protocol.

Week / Phase	Dose	At 2.5 mg/mL	At 5 mg/mL	Notes
Low research dose	200 mcg	20 units (1 mg/mL)	10 units (2 mg/mL)	Lower end of commonly cited research doses. No human trial data to support this dosing.
Mid research dose	350 mcg	35 units (1 mg/mL)	17.5 units (2 mg/mL)	Mid-range commonly cited in research community.
High research dose	500 mcg	50 units (1 mg/mL)	25 units (2 mg/mL)	Upper end of commonly cited doses. No human safety studies at any dose level.

Units shown assume a standard U-100 insulin syringe (100 units = 1 mL). Always confirm your vial concentration with your pharmacy.

Dose Calculator

Enter your prescribed dose and vial concentration to calculate how many units to draw.

mg ↔ Units Dose Calculator

Convert between milligrams and insulin-syringe units for compounded GLP-1 medications. Uses a standard U-100 syringe (100 units = 1 mL).

Medication

Vial Concentration (mg/mL)

Dose (mg)

Units (U-100 syringe)100 units

Volume1.000 mL

2.5 mg at 2.5 mg/mL → 1.000 mL → 100 units on a U-100 (100-unit / 1 mL) insulin syringe

Always verify calculations with your prescribing provider or pharmacist before administering any medication. This calculator is for reference only.

Injection Sites

Subcutaneous (research)

Research protocols typically describe subcutaneous injection.

Standard subcutaneous technique
Animal studies used various injection routes

Storage Instructions

Lyophilized (freeze-dried) powder: store frozen or refrigerated
After reconstitution: refrigerate, typically 2–4 weeks shelf life
Use bacteriostatic water for reconstitution (extends shelf life vs sterile water)
Protect from light

Common Side Effects

Contact your healthcare provider if side effects are severe or persistent.

Unknown — no human clinical trial data
Nausea reported anecdotally
Injection site reactions
Unknown long-term effects

Frequently Asked Questions

Is BPC-157 legal?

BPC-157 is not FDA-approved as a drug. In August 2023, the FDA issued a warning against compounded drug products containing BPC-157. It remains available as a 'research chemical' in the US with varying regulatory status. Legality differs by country.

What does BPC-157 do?

Animal studies suggest BPC-157 may accelerate healing of tendons, ligaments, muscles, and gastric tissue, and may have neuroprotective and anti-inflammatory effects. However, there are no controlled human clinical trials confirming these effects or establishing safe dosing.

Is BPC-157 a GLP-1 drug?

No. BPC-157 is completely unrelated to GLP-1 drugs (semaglutide, tirzepatide). It is derived from gastric juice proteins and has a different mechanism of action. It is not used for weight loss or diabetes in any FDA-approved capacity.